Viewing data from:

CLONIDINE HYDROCHLORIDE

ANDA

CLONIDINE HYDROCHLORIDE | A077901 | PRINSTON PHARMACEUTICAL INC

3 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 7 NDCs

Highest NADAC/Unit

$0.0404

per ea

Lowest NADAC/Unit

$0.0246

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
43547056710CLONIDINE HCL 0.3 MG TABLET	$0.0404	EA	Generic	—	2026-06-17
43547056610CLONIDINE HCL 0.2 MG TABLET	$0.0325	EA	Generic	—	2026-06-17
43547056611CLONIDINE HCL 0.2 MG TABLET	$0.0325	EA	Generic	—	2026-06-17
00904744361CLONIDINE HCL 0.2 MG TABLET	$0.0325	EA	Generic	—	2026-06-17
43547056510CLONIDINE HCL 0.1 MG TABLET	$0.0246	EA	Generic	—	2026-06-17
43547056511CLONIDINE HCL 0.1 MG TABLET	$0.0246	EA	Generic	—	2026-06-17
00904744261CLONIDINE HCL 0.1 MG TABLET	$0.0246	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain5 active DMFs6 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

PCASCLONIDINE HYDROCHLORIDE

DMF 47781983

UNICHEM LABORATORIES LTDCLONIDINE HYDROCHLORIDE USP

DMF 169292003

ALEMBIC PHARMACEUTICALS LTDCLONIDINE HYDROCHLORIDE USP

DMF 223622008

YUNG ZIP CHEMICAL IND CO LTDCLONIDINE HYDROCHLORIDE

DMF 239062010

ENALTEC LABS PRIVATE LTDCLONIDINE HYDROCHLORIDE USP

DMF 313862017

LUSOCHIMICA SPAInactiveCLONIDINE HYDROCHLORIDE

DMF 59981985

ORCHIMIE SAInactiveCLONIDINE HYDROCHLORIDE

DMF 60141985

YUNG ZIP CHEMICAL INDUSTRY COMPANY LTDInactiveCLONIDINE HYDROCHLORIDE

DMF 61281985

DAIWA PHARMACEUTICAL CO LTDInactiveCLONIDINE HYDROCHLORIDE

DMF 63071986

UNICHEM LABORATORIES LTDInactiveCLONIDINE HYDROCHLORIDE

DMF 63571986

KV PHARMACEUTICAL COInactiveCLONIDINE HYDROCHLORIDE CONTROLLED RELEASE CAPSULES 0.2 MG.

DMF 76311988

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 0.1MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Mar 9, 2007

No patent or exclusivity listings for this strength.

#002 — 0.2MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Mar 9, 2007

#003 — 0.3MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Mar 9, 2007